Vimentin (RV202) PerCP-Cy5.5 Antibody sc-32322 PCPC5 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(2) Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hostsJournal for immunotherapy of cancerSeptember 1, 2023Veitch M, Beaumont K, Pouwer R, Chew HY, Frazer IH, Soyer HP, Campbell S, Dymock BW, Harvey A, Cock TA, et al.

(3) Regulation of ERα-dependent breast cancer metastasis by a miR-29a signalingJournal of experimental & clinical cancer research : CRApril 20, 2023Lü J, Zhao Q, Guo Y, Li D, Xie H, Liu C, Hu X, Liu S, Hou Z, Wei X, et al.

(5) A novel junctional epithelial cell line, mHAT-JE01, derived from incisor epithelial cellsJournal of oral biosciencesMarch 1, 2023Ikezaki S, Otsu K, Kumakami-Sakano M, Harada H.

(8) ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Experimental & molecular medicineJanuary 1, 2023Jeong JH, Park SH, Kim H, Nam HY, Kim SH, Jeong M, Kong MJ, Son J, Jeong JE, Song JH, et al.

(9) IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancerTheranosticsJanuary 1, 2023Zhao Q, Qian L, Guo Y, Lü J, Li D, Xie H, Wang Q, Ma W, Liu P, Liu Y, et al.

(11) Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transitionJournal of cancer research and clinical oncologyDecember 1, 2022Kapeleris J, Müller Bark J, Ranjit S, Richard D, Vela I, O'Byrne K, Punyadeera C.

(12) Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancerScientific reportsOctober 12, 2022Edachery S, Patil P, Mohan R, Aradhya B, Shetty J, Kabekkodu SP, Santra MK, Gonchigar SJ, Shetty P.

(13) Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinomaThe Journal of biological chemistryOctober 1, 2022Chu TH, Ko CY, Tai PH, Chang YC, Huang CC, Wu TY, Chan HH, Wu PH, Weng CH, Lin YW, et al.

(14) TGF-β-Upregulated Lnc-Nr6a1 Acts as a Reservoir of miR-181 and Mediates Assembly of a Glycolytic ComplexNon-coding RNASeptember 15, 2022Polo-Generelo S, Torres B, Guerrero-Martínez JA, Camafeita E, Vázquez J, Reyes JC, Pintor-Toro JA.

(15) Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy ResistanceInternational journal of molecular sciencesAugust 31, 2022Radić M, Vlašić I, Jazvinšćak Jembrek M, Horvat A, Tadijan A, Sabol M, Dužević M, Herak Bosnar M, Slade N.

(16) Isoliquiritigenin ameliorates advanced glycation end-products toxicity on renal proximal tubular epithelial cellsEnvironmental toxicologyAugust 1, 2022Lin CY, Lin YC, Paul CR, Hsieh DJ, Day CH, Chen RJ, Kuo CH, Ho TJ, Shibu MA, Lai CH, et al.

(19) Dexamethasone resets stable association of nuclear Snail with LSD1 concomitant with transition from EMT to partial EMTBiochemistry and biophysics reportsJuly 1, 2022Okuda S, Yamakado N, Higashikawa K, Uetsuki R, Ishida F, Rizqiawan A, Ono S, Mizuta K, Kamata N, Tobiume K.

(20) PRR16/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 KinaseBiomolecules & therapeuticsJuly 1, 2022Kang GJ, Park JH, Kim HJ, Kim EJ, Kim B, Byun HJ, Yu L, Nguyen TM, Nguyen TH, Kim KS, et al.

Vimentin (RV202) PerCP-Cy5.5 Antibody